The largest holder of Globus Medical stock is BlackRock Advisors LLC, with 10.3 million shares (9.22% of the company), worth about $839.00 million as of September 25, 2026. The 10 largest holders together own 43.9%.
In Q2 2026, 625 institutional holdings reports listed 130.0 million shares worth $9.64 billion, up 18.2% in shares from Q1 2026.
Insiders reported 38 transactions in the last two years: 21 sales worth $38.94 million and no purchases. The newest one on file is from February 25, 2026 (Huller Kelly Grace, General Counsel).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through February 25, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| BlackRock Advisors LLC | 10.3 million | 9.22% | $839.0M |
| Janus Henderson Investors US LLC | 8.2 million | 7.33% | $667.0M |
| Vanguard Capital Management LLC | 5.1 million | 4.57% | $416.0M |
| Vanguard Portfolio Management LLC | 5.0 million | 4.47% | $406.0M |
| Invesco Advisers, Inc. | 4.3 million | 3.85% | $351.0M |
| Kayne Anderson Rudnick Investment Management LLC | 4.3 million | 3.83% | $348.0M |
| State Street Corporation | 3.7 million | 3.32% | $302.0M |
| Sculptor Capital LP | 3.0 million | 2.68% | $244.0M |
| JPMorgan Investment Management, Inc. | 2.7 million | 2.45% | $223.0M |
| Burgundy Asset Management Ltd. | 2.4 million | 2.14% | $195.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 625 | 130.0 million | $9.6B |
| Q1 2026 | 628 | 110.0 million | $9.4B |
| Q4 2025 | 601 | 112.0 million | $9.8B |
| Q3 2025 | 516 | 120.0 million | $6.9B |
| Q2 2025 | 503 | 115.0 million | $6.8B |
| Q1 2025 | 535 | 110.0 million | $8.1B |
| Q4 2024 | 517 | 109.0 million | $9.0B |
| Q3 2024 | 467 | 111.0 million | $7.9B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Huller Kelly Grace | Feb 25, 2026 | General Counsel | Conversion of Exercise of derivative security at price 43.58 per share. | $871,600 |
| Huller Kelly Grace | Feb 25, 2026 | General Counsel | Sale at price 94.50 per share. | $1.9M |
| Huller Kelly Grace | Feb 12, 2026 | General Counsel | Conversion of Exercise of derivative security at price 45.64 per share. | $456,400 |
| Huller Kelly Grace | Feb 12, 2026 | General Counsel | Sale at price 87.67 per share. | $876,700 |
| Kline Kyle | Jan 8, 2026 | Chief Financial Officer | Conversion of Exercise of derivative security at price 51.87 per share. | $186,421 |
| Kline Kyle | Jan 8, 2026 | Chief Financial Officer | Sale at price 101.10 per share. | $363,353 |
| Norwalk Leslie V | Jan 8, 2026 | Director | Sale at price 101.10 per share. | $202,200 |
| Norwalk Leslie V | Dec 12, 2025 | Director | Sale at price 88.85 per share. | $355,400 |
| Paul David C | Dec 8, 2025 | Officer, Director and Beneficial Owner | Conversion of Exercise of derivative security at price 25.52 per share. | $877,250 |
| Kline Kyle | Dec 1, 2025 | Chief Financial Officer | Conversion of Exercise of derivative security at price 53.14 - 64.44 per share. | $1.1M |
| Kline Kyle | Dec 1, 2025 | Chief Financial Officer | Sale at price 90.00 per share. | $1.7M |
| Huller Kelly Grace | Nov 25, 2025 | General Counsel | Conversion of Exercise of derivative security at price 25.96 per share. | $194,700 |
Newest 12 of 38 insider transactions in the last two years.
BlackRock Advisors LLC, with 9.22% of the company (as of September 25, 2026). Next: Janus Henderson Investors US LLC (7.33%) and Vanguard Capital Management LLC (4.57%).
625 institutional holdings reports listed Globus Medical shares in Q2 2026, 130.0 million shares in all worth $9.64 billion.
In the last two years insiders reported 21 sales and no purchases (38 transactions in all); the newest on file is from February 25, 2026.